DrugPatentWatch Database Preview
Amicus Theraps Us Company Profile
» See Plans and Pricing
What is the competitive landscape for AMICUS THERAPS US, and when can generic versions of AMICUS THERAPS US drugs launch?
AMICUS THERAPS US has one approved drug.
There are sixteen US patents protecting AMICUS THERAPS US drugs.
There are one hundred and seven patent family members on AMICUS THERAPS US drugs in twenty-six countries and sixteen supplementary protection certificates in fourteen countries.
Summary for Amicus Theraps Us
| International Patents: | 107 |
| US Patents: | 16 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Amicus Theraps Us
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amicus Theraps Us | GALAFOLD | migalastat hydrochloride | CAPSULE;ORAL | 208623-001 | Aug 10, 2018 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Amicus Theraps Us | GALAFOLD | migalastat hydrochloride | CAPSULE;ORAL | 208623-001 | Aug 10, 2018 | RX | Yes | Yes | 9,000,011 | Start Trial | Start Trial | ||||
| Amicus Theraps Us | GALAFOLD | migalastat hydrochloride | CAPSULE;ORAL | 208623-001 | Aug 10, 2018 | RX | Yes | Yes | 10,799,491 | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Amicus Theraps Us Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Luxembourg | 93312 | Start Trial |
| Australia | 2018220047 | Start Trial |
| Japan | 2018138564 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Amicus Theraps Us Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2787345 | CR 2016 00055 | Denmark | Start Trial | PRODUCT NAME: MIGALASTAT ELLER ET SALT HERAF, HERUNDER HYDROGENKLORIDSALTET; REG. NO/DATE: EU/1/15/1082 20160531 |
| 2787345 | PA2016033,C2787345 | Lithuania | Start Trial | PRODUCT NAME: MIGALASTATAS ARBA JO DRUSKA, ISKAITANT IR HIDROCHLORIDO DRUSKA; REGISTRATION NO/DATE: EU/1/15/1082 20160526 |
| 2787345 | 300843 | Netherlands | Start Trial | PRODUCT NAME: MIGALASTAT OF EEN ZOUT DAARVAN, WAARONDER HET HYDROCHLORIDEZOUT; REGISTRATION NO/DATE: EU/1/15/1082 20160531 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
